Company Profile
Vaxcell-Bio Therapeutics develops and anticancer immunotherapy products in South Korea. Founded in 2010, the company is headquartered in Hwasun-eup, South Korea.
#1301 ๐ฐ๐ท KR
KOSDAQยท323990.KQ
โฉ3585.0000
$2.47ยทโฌ2.17
-6.76% (24h)
Last updated: 1 second ago
Market Cap
โฉ83.08B
$57.24M ยท โฌ50.22M
Volume (24h)
73.9K shrsยท โฉ264.94M
$182.54K ยท โฌ160.16K
Last Close (7D)
โฉ3585.00
$2.47 ยท โฌ2.17
Vaxcell-Bio Therapeutics develops and anticancer immunotherapy products in South Korea. Founded in 2010, the company is headquartered in Hwasun-eup, South Korea.
52-Week Range
SEC filings for this ticker are not available yet.
Americas
Europe
Asia